Therapeutic effects of high-dose inhaled nitric oxide gas against post-covid syndrome, diabetes or AIDS

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

A therapeutic effect of high-dose nitric oxide gas inhalation (more than 1000 ppm) on patients with post-COVID syndrome, diabetes or AIDS is shown. It has been proposed that nitrosonium cations (NO+), derivatives of nitric oxide gas, the emergence of which in the blood or organ tissues of patients is related to disproportion reaction of NO molecules, forming a co-ordinate bond with the Fe2+ion, carried by transferrin or entered into the labile (free) iron pool may act as a therapeutic agent. It is quite probable that treatment of HIV infection (as well as the earlier revealed effect of NO gas on the patients with COVID-19) could be provided by the effects of S-nitrosylation of NO+ cations on thiol groups of viral proteases and host proteins. A beneficial effect of NO+ cations which emerged in the reaction of NO gas molecules in patients with post-COVID syndrome or diabetes can be also associated with an inhibitory effect of these cations on the thiol-containig proteins that are involved in apoptosis.

作者简介

A. Vanin

N.N. Semenov Federal Research Center for Chemical Physics

Email: vanin.dnic@gmail.com
Moscow, Russia

A. Pekshev

N.E. Bauman Moscow State Technical University

Moscow, Russia

E. Pechyonkin

Stavropol State Medical University

Stavropol, Russia

A. Vagapov

N.E. Bauman Moscow State Technical University

Moscow, Russia

N. Sharapov

N.E. Bauman Moscow State Technical University

Moscow, Russia

参考

  1. А. В. Шиповалов, А. Ф. Ванин, О. В. Пьянков и др., Биофизика, 67 (5), 969 (2022).
  2. A. F. Vanin, V. A. Tronov, and R. R. Borodulin, Cell Biochem. Biophys., 79, 93 (2021).
  3. А. Ф. Ванин, Д. И. Телегина, В. Д. Микоян и др., Биофизика, 67 (5), 938 (2022).
  4. Е. В. Печёнкин, А. В. Коврижкин, А. В. Пекшев и др., Биофизика, 67 (6), 1251 (2022).
  5. А. Ф. Ванин, А. В. Пекшев, А. Б. Вагапов и др., Биофизика, 66 (1), 183 (2021).
  6. L. J. Ignarro, Pharmacol. Toxicol., 67, 1 (1990).
  7. P. C. Ford, Inorg. Chem., 49, 6226 (2010).
  8. A. A. Timoshin, V. L. Lakomkin, A. A. Abramov, et al., Eur. J. Pharmacol., 765, 525 (2015).
  9. A. F. Vanin, Cell Biochem. Biophys., 77, 279 (2019).
  10. А. Ф. Ванин, Биофизика, 65, 4, 421 (2020).
  11. A. F. Vanin, Appl. Magn. Reson., 51, 851 (2020).
  12. V. Yu. Titov and A. N. Osipov, Redox Rep., 22, 2 (2017).
  13. T. H. Han, J. M. Fucuto, and J. C. Liao, Nitric Oxide Biol. Chem., 10, 74 (2004).
  14. Q. Li, C. Li, H. K. Mahtani, et al., J. Biol. Chem., 289, 19917 (2014).
  15. A. S. Hurtsen, I. Z. Nilsson, E. M. Dogan, et al., Drug Design, Development &Therapy, 14, 635 (2020).
  16. F. Blasina, L. Vaamonde, F. Silvera, et al., Pulmonary Pharmacol. Ther., 54, 68 (2019).
  17. Yu. P. Vedernikov, P. I. Mordvintcev, I. V. Malenkova, et al., Eur. J. Pharmacol., 211, 313 (1992).
  18. А. Ф. Ванин, Биофизика, 65, 818 (2020).
  19. S. Castro-Gonzalez, M. Colomer-Lluch, and R. Serra-Moreno, AIDS Research and Human Retroviruses, 34, 9, 739 (2018).
  20. Н. Н. Петрищев, О. В. Халепо, Ю. А. Вавиленкова и др., Региональное кровообращение и микроциркуляция, 19, 3 (2020).
  21. М. Ю. Мартынов, А. И. Боголепов и А. Н. Ясманова, Журн. неврологии и психиатрии им. С.С. Корсакова, 121, 93 (2021).
  22. L. Perico, A. Benigni, F. Casivaghi, et al., Nat. Rev. Nephrol., 17, 46 (2021).
  23. A. K. V. Iyer, Y. Rojansakul, and N. Azad, Nitric Oxide Biol. Chem., 42, 9 (2014).
  24. Y. M. Kim, H. T. Chung, R. L. Symmons, et al., J. Biol. Chem., 275, 10954 (2000).

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russian Academy of Sciences, 2023